Network biology as a new approach to drug discovery

Current Opinion in Drug Discovery and Development

Volumn 13, Issue 5, 2010, Pages 524-526

  Lowe, John A ^a   Jones, Phil ^b   Wilson, Dawid M ^c  

^a JL3 Pharma LLC   (United States)

^b Merck Sharp & Dohme Limited   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; NEW DRUG; PLX 4032;

ALZHEIMER DISEASE; ANTINEOPLASTIC ACTIVITY; CANCER RESEARCH; CARCINOGENESIS; DEPRESSION; DRUG DESIGN; DRUG EFFICACY; DRUG INDUSTRY; DRUG RESEARCH; DRUG TARGETING; GENETIC IDENTIFICATION; HUMAN; MEDICAL DECISION MAKING; REVIEW;

ANIMALS; DRUG DISCOVERY; DRUG INDUSTRY; HUMANS; METABOLIC NETWORKS AND PATHWAYS; PHARMACEUTICAL PREPARATIONS; SYSTEMS BIOLOGY;

EID: 77956395608     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)